This inventor holds 6 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignee: Duke University. Active years: 2019-2025.
Company Filing History:
Years Active: 2019-2025
Title: Kaitlyn Andreano: Innovator in Breast Cancer Treatment
Introduction
Kaitlyn Andreano is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of cancer treatment, particularly focusing on breast cancer therapies. With a total of 6 patents to her name, her work is paving the way for innovative medical solutions.
Latest Patents
One of her latest patents involves the use of lasofoxifene for the treatment of estrogen receptor positive (ER) cancer in women. This patent outlines methods for administering an effective amount of lasofoxifene, a pharmaceutically acceptable salt, or a prodrug thereof. Additionally, it includes the detection of mutations in the Estrogen Receptor 1 (ESR1) gene that contribute to endocrine resistance in ER cancers. This groundbreaking work aims to improve treatment outcomes for patients facing endocrine-resistant cancers.
Career Highlights
Kaitlyn Andreano is affiliated with Duke University, where she conducts her research and develops her innovative treatments. Her dedication to advancing cancer therapies has positioned her as a key figure in the medical research community.
Collaborations
She collaborates with esteemed colleagues, including Ching-yi Chang and Donald P McDonnell, to further enhance her research efforts and contribute to the scientific community.
Conclusion
Kaitlyn Andreano's work in breast cancer treatment exemplifies the impact of innovation in medicine. Her patents and research are crucial in the fight against cancer, offering hope for improved therapies and patient outcomes.